POCI · Precision Optics Corporation, Inc.

Precision Optics Corporation, Inc. executed a material underwriting agreement with Lucid Capital Markets, LLC on March 27, 2026, facilitating the issuance and sale of 2,777,777 shares of common stock at a public offering price of $3.60 per share. This upsized, oversubscribed offering, which closed on March 30, 2026, provides the company with approximately $10.7 million in net proceeds assuming full exercise of the 45-day over-allotment option for an additional 416,667 shares. The transaction strengthens the company's liquidity position, with proceeds designated for working capital and general corporate purposes, supporting ongoing operations in its medical and defense/aerospace optics businesses. Key terms include an underwriting discount of up to 6.5% and expense reimbursement not exceeding $90,000. Notably, the company issued Representative’s Warrants to the Underwriter for 159,722 shares at an exercise price of $4.21, exercisable starting March 30, 2026, and expiring March 27, 2031, under a Securities Act exemption. Participation by insiders including CEO Dr. Joseph N. Forkey, CFO Wayne Coll, and COO Joseph Traut signals management alignment. The offering utilized the company's effective shelf registration on Form S-3 (No. 333-280047), with press releases on March 26 and 27 announcing the proposal and pricing.